Topic: Diabetes
CHICAGO (Reuters) - A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like GlaxoSmithKline's Avandia, U.S. researchers said on Wednesday. The researchers had believed Avandia and Takeda Pharmaceutical Co's Actos work by ...
FDA bars new patients from enrolling in safety study of diabetes drug tied to heart risksFederal health officials say new patients should not be enrolled in a study of GlaxoSmithKline's controversial diabetes pill Avandia, after experts last week said the drug increases ...
Bristol-Myers expected to focus on drug research progress, approval prospects in 2Q reportDrugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results ...
CHICAGO (Reuters) - The U.S. Food and Drug Administration has warned Abbott Laboratories' diabetes care unit about manufacturing problems at its Alameda, California plant, a letter released Tuesday said. In a letter dated July 2, FDA said its inspectors found Abbott's Freestyle ...
Product recalls: dietary supplementsThe following recalls have been announced: _ Good Health Inc., of Canutillo, Texas, is recalling select lots of the dietary supplement Vialipro because they could contain a compound that is chemically similar to the erectile dysfunction drug sildenafil. This ...
A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of ...
Diabetes drug Avandia faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems. The committee, convened at the request of the Food and Drug ...
British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts who ...
Indian scientists said Tuesday they had made a breakthrough that could lead to diabetics needing to inject themselves only once a month or less, rather than every day. Researchers at the National Institute of Immunology in New Delhi said they had successfully ...
UK pharmaceutical giant GlaxoSmithKline kept the dangers of its top-selling diabetes drug Avandia out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting ...
